mutation analysis

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

Natural History Study of FDXR Mutation-related Mitochondriopathy

Natural History Study of SLC25A46 Mutation-related Mitochondriopathy

Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX)

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy